Health High Aneuploidy Scores Linked to Poorer Immunotherapy Outcomes Findings from a biomarker analysis of the phase 3 AtTEnd trial (NCT03603184) indicate that high whole-exome sequencing (WES)–aneuploidy scores (W-AS) may serve as a... Editorial9 hours ago